Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-06-15Clinical Trial Update: Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis [Phase 4]
Phase 4 trial evaluating etanercept for active axial ankylosing spondylitis completed with results posted in 2010.
-
FDA approval · 2010-06-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis [Phase 3]
Phase 3 clinical trial update reporting safety and efficacy results for adalimumab in patients with active ankylosing spondylitis.
-
FDA approval · 2010-04-26FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)
FDA approved a supplemental application for ZYBIC (meloxicam) submitted by Redmont Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED) [Phase 4]
A completed Phase 4 analysis examined peripheral blood mononuclear cells from patients with Ankylosing Spondylitis during infliximab treatme…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-01Clinical Trial Update: Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis [Phase 4]
Phase 4 trial evaluating tramadol/acetaminophen (Ultracet) as add-on therapy for ankylosing spondylitis has been completed.
-
FDA approval · 2010-03-19FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for diclofenac sodium from Aurobindo Pharma Limited. This action authorizes changes to the approved …
-
FDA approval · 2010-03-17FDA Approved: INDOMETHACIN — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original NDA for indomethacin from Fresenius Kabi USA, LLC. The approval covers indications for inflammatory and musculo…
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial of adalimumab in active ankylosing spondylitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440) [Phase 4]
A Phase 4 trial evaluating entheseal inflammation using ultrasound Doppler in spondyloarthropathies treated with infliximab was terminated; …
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: A Study Investigating an Exercise and Education Programme for Individuals With Ankylosing Spondylitis [Phase 3]
A Phase 3 study evaluating an exercise and education programme for individuals with ankylosing spondylitis has completed.
-
FDA approval · 2009-09-24FDA Approved: MELOXICAM — Supplemental Application (Carlsbad Technology, Inc.)
The FDA approved a supplemental application for Meloxicam from Carlsbad Technology, Inc., indicating the supplemental action for the generic…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Study Investigating Enbrel Treatment for Ankylosing Spondylitis
The clinical trial evaluating Enbrel (etanercept) for ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain [Phase 4]
A Phase 4 clinical trial evaluating etanercept in subjects with ankylosing spondylitis in Spain has completed; results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects [Phase 1, Phase 2]
This update reports the completion of Phase 1 and Phase 2 trials evaluating intra-articular delivery of tgAAC94 for inflammatory arthritis, …
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial evaluating safety and efficacy of golimumab in active ankylosing spondylitis has completed, with results posted in 2009. The t…
-
FDA approval · 2009-05-13FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc.
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis [Phase 2, Phase 3]
Clinical trial update evaluating Tripterygium Capsule for early ankylosing spondylitis in Phase 2 and Phase 3, sponsored by Sun Yat-sen Univ…
-
FDA approval · 2009-04-24FDA Approved: SIMPONI — Original Application (Janssen Biotech, Inc.)
FDA approved the original Biologics License Application for Simponi (golimumab) from Janssen Biotech, Inc.
-
FDA approval · 2009-03-06FDA Approved: INDOMETHACIN — Original Application (KVK-Tech, Inc.)
FDA approved an original application for Indomethacin by KVK-Tech, Inc., establishing a generic version of indomethacin. The approval signif…
-
CLINICAL_TRIALS withdrawal · 2009-01-05Clinical Trial Update: Methotrexate in the Treatment of Axial Spondyloarthritis [Phase 4]
Phase 4 clinical trial evaluating methotrexate for axial spondyloarthritis was withdrawn.
-
CLINICAL_TRIALS research · 2008-09-08Clinical Trial Update: Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
Clinical trial comparing health-related quality of life and disease-related costs among ankylosing spondylitis, rheumatoid arthritis, and sy…
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: Evaluation of a Patient Education Program for Ankylosing Spondylitis [NA]
A completed clinical trial evaluating a patient education program for individuals with ankylosing spondylitis and spondyloarthritis.
-
FDA approval · 2008-07-25FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
The FDA has approved a supplemental application for naproxen filed by Zameer Pharmaceuticals LLC.
-
EMA guidance · 2008-06-26EMEA recommends strengthening warnings and contraindications for etoricoxib-containing medicines used in the treatment of rheumatoid arthritis and ankylosing spondylitis
EMA recommends stronger warnings and contraindications for etoricoxib-containing medicines used to treat rheumatoid arthritis and ankylosing…